SK99195A3 - Heteroaromatic compounds with antipsychotic effect - Google Patents

Heteroaromatic compounds with antipsychotic effect Download PDF

Info

Publication number
SK99195A3
SK99195A3 SK991-95A SK99195A SK99195A3 SK 99195 A3 SK99195 A3 SK 99195A3 SK 99195 A SK99195 A SK 99195A SK 99195 A3 SK99195 A3 SK 99195A3
Authority
SK
Slovakia
Prior art keywords
formula
piperazinyl
benzisothiazol
butyl
compound
Prior art date
Application number
SK991-95A
Other languages
English (en)
Slovak (sk)
Inventor
Mark H Norman
Frank Navas Iii
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SK99195A3 publication Critical patent/SK99195A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK991-95A 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic effect SK99195A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds
PCT/GB1994/000265 WO1994018196A1 (en) 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic activity

Publications (1)

Publication Number Publication Date
SK99195A3 true SK99195A3 (en) 1995-12-06

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
SK991-95A SK99195A3 (en) 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic effect

Country Status (15)

Country Link
EP (1) EP0683778A1 (xx)
JP (1) JPH08506337A (xx)
CN (1) CN1117731A (xx)
AU (1) AU6005194A (xx)
BG (1) BG99839A (xx)
CA (1) CA2155758A1 (xx)
CZ (1) CZ204495A3 (xx)
FI (1) FI953777A (xx)
GB (1) GB9302622D0 (xx)
HU (1) HUT73654A (xx)
IL (1) IL108601A0 (xx)
MX (1) MX9401080A (xx)
SK (1) SK99195A3 (xx)
WO (1) WO1994018196A1 (xx)
ZA (1) ZA94891B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
WO2002039988A2 (en) * 2000-11-14 2002-05-23 Merck Patent Gmbh Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
WO2002066469A2 (en) * 2001-02-16 2002-08-29 Aventis Pharmaceuticals Inc. Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
ES2280602T3 (es) 2001-07-26 2007-09-16 Merck Patent Gmbh Uso de 2-(5-(4-fluorofenil)-3-piridilmetilaminometil)-cromano y sus sales fisiologicamente aceptables.
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
AU2005263592A1 (en) * 2004-07-20 2006-01-26 Siena Biotech S.P.A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
EP2736905A4 (en) * 2011-07-28 2015-07-29 Mapi Pharma Ltd INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF LURASIDONE AND SALTS THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
JP2660407B2 (ja) * 1986-09-26 1997-10-08 住友製薬株式会社 新規なイミド誘導体
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives

Also Published As

Publication number Publication date
HUT73654A (en) 1996-09-30
CA2155758A1 (en) 1994-08-18
WO1994018196A1 (en) 1994-08-18
CZ204495A3 (en) 1996-03-13
EP0683778A1 (en) 1995-11-29
FI953777A0 (fi) 1995-08-09
HU9501881D0 (en) 1995-08-28
JPH08506337A (ja) 1996-07-09
GB9302622D0 (en) 1993-03-24
BG99839A (bg) 1996-02-28
IL108601A0 (en) 1994-05-30
AU6005194A (en) 1994-08-29
ZA94891B (en) 1995-08-10
MX9401080A (es) 1994-08-31
CN1117731A (zh) 1996-02-28
FI953777A (fi) 1995-08-09

Similar Documents

Publication Publication Date Title
EP1954696B1 (en) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
SK96494A3 (en) Piperazine and piperidine derivatives, and their use as antipsychotic
JP3886897B2 (ja) ベンゾチアゾール誘導体
FI91868B (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
US8604050B2 (en) Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
EP1833836B1 (en) Imidazo-fused thiazolo [4,5-b] pyridine based tricyclic compounds and pharmaceutical compositions comprising same
JP4244189B2 (ja) アデノシン受容体リガンドとしての7−アミノ−ベンゾチアゾール誘導体
SK99195A3 (en) Heteroaromatic compounds with antipsychotic effect
WO2007038669A9 (en) Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
CZ300709B6 (cs) 5-Pyridyl-1,3-azolové slouceniny, zpusob výroby a použití
EP0682656A1 (en) Use of phenyl heteroaryl ureas as 5ht 2c? receptor antagonists and urea compounds
IL179364A (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
JP2000511534A (ja) ベンゾオキサジノンドーパミンd4受容体アンタゴニスト
JPH07103110B2 (ja) 潰瘍の予防及び治療剤
KR100699615B1 (ko) 벤족사졸 유도체 및 아데노신 수용체 리간드로서의 이들의용도
JP4283116B2 (ja) ベンゾチアゾール
Walczyński et al. Histamine H1 receptor ligands: Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology
CN101346385A (zh) 新化合物
AU2006327981A1 (en) Thienopyridine derivatives as modulators of metabotropic glutamate receptors
JPS61205275A (ja) 新規の8‐チオテトラヒドロキノリン誘導体及びそれらの塩
KR100581703B1 (ko) 아데노신 수용체 조절제로서의 벤조티오펜